Airain Ltd’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Airain Ltd’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-37,651	Closed	-$348K	–	992
2016 Q1	$348K	Buy	+37,651	New	+$405K	0.02%	529
2015 Q4	–	Sell	-73,454	Closed	-$1.21M	–	1130
2015 Q3	$1.21M	Buy	+73,454	New	+$1.5M	0.07%	305
2014 Q4	–	Sell	-11,325	Closed	-$128K	–	993
2014 Q3	$128K	Buy	+11,325	New	+$129K	0.01%	723
2013 Q4	–	Sell	-15,055	Closed	-$217K	–	745
2013 Q3	$217K	Buy	+15,055	New	+$230K	0.04%	385

Other funds holding MNTA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Airain Ltd's MNTA Position: Q2 2016 in Review

Airain Ltd sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q2 2016, closing a stake of 37,651 shares — an estimated $348K sold.

Airain Ltd first reported a position in MNTA in Q3 2013 and held it in 4 quarters. The position peaked at $1.21M in Q3 2015. 146 funds tracked by Wall St. Rank hold MNTA as of Q2 2016.

Airain Ltd reported no remaining Momenta Pharmaceuticals, Inc. position as of Q2 2016 after selling out during the quarter.
Airain Ltd sold 37,651 Momenta Pharmaceuticals, Inc. shares in Q2 2016, an estimated $348K.
Airain Ltd first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2013 and held it in 4 quarters.
Airain Ltd's Momenta Pharmaceuticals, Inc. position peaked at $1.21M in Q3 2015.
146 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q2 2016.

Based on Airain Ltd's 13F filing for Q2 2016, filed 5 Aug 2016.